Mario Masellis

Absence of linkage for schizophrenia on the short arm of chromosome 5 in multiplex Canadian families.

Psychiatric pharmacogenetics: personalizing psychostimulant therapy in attention-deficit/hyperactivity disorder.

Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects.

Pharmacogenomics in schizophrenia: the quest for individualized therapy.

Quality of life in OCD: differential impact of obsessions, compulsions, and depression comorbidity.

Polymorphisms in glutamate decarboxylase genes: analysis in schizophrenia.

The dopamine-4 receptor gene associated with binge eating and weight gain in women with seasonal affective disorder: an evolutionary perspective.

A birth-season/DRD4 gene interaction predicts weight gain and obesity in women with seasonal affective disorder: A seasonal thrifty phenotype hypothesis.

Novel 5-HTTLPR allele associates with higher serotonin transporter binding in putamen: a [(11)C] DASB positron emission tomography study.

Cholinesterase inhibitors in Alzheimer's disease and Lewy body spectrum disorders: the emerging pharmacogenetic story.

Intra-familial clinical heterogeneity due to FTLD-U with TDP-43 proteinopathy caused by a novel deletion in progranulin gene (PGRN).

Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia.

Forward Look: Tenth Anniversary of the Human Genome Sequence and 21 Century Postgenomics Global Health - A Close Up on Africa and Women's Health.

Ethical and Policy Considerations in the Application of Pharmacogenomic Testing for Tardive Dyskinesia: Case Study of the Dopamine D3 Receptor.

End of the Beginning and Public Health Pharmacogenomics: Knowledge in 'Mode 2' and P5 Medicine.

Fluorodeoxyglucose positron emission tomography in semantic dementia after 6 months of memantine: an open-label pilot study.

Modulation of the default-mode network between rest and task in Alzheimer's Disease.

Investigation of C9orf72 in 4 Neurodegenerative Disorders.

Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome.

Public Health Pharmacogenomics and the Design Principles for Global Public Goods - Moving Genomics to Responsible Innovation.

A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies.

Developing physician consensus on the reporting of patients with mild cognitive impairment and mild dementia to transportation authorities in a region with mandatory reporting legislation.

Early-onset dementias: diagnostic and etiological considerations.

Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians.

Taking the Kidney Personally: The Quest for Novel Antigens of Idiopathic Membranous Nephropathy through Proteomic Approaches -?

Differentiating between visual hallucination-free dementia with Lewy bodies and corticobasal syndrome on the basis of neuropsychology and perfusion single-photon emission computed tomography.

Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis.

White matter hyperintensity burden in elderly cohort studies: The Sunnybrook Dementia Study, Alzheimer's Disease Neuroimaging Initiative, and Three-City Study.

DRD2 and SLC6A3 moderate impact of maternal depressive symptoms on infant cortisol.

Physiological fluctuations in white matter are increased in Alzheimer's disease and correlate with neuroimaging and cognitive biomarkers.

Attenuation of functional hyperemia to visual stimulation in mild Alzheimer's disease and its sensitivity to cholinesterase inhibition.

Orthostatic hypotension, cerebral hypoperfusion, and visuospatial deficits in Lewy body disorders.

Summary cortisol reactivity indicators: Interrelations and meaning.

MATERNAL SELF-REPORTED DEPRESSIVE SYMPTOMS AND MATERNAL CORTISOL LEVELS INTERACT TO PREDICT INFANT CORTISOL LEVELS.

Characterization of Movement Disorder Phenomenology in Genetically Proven, Familial Frontotemporal Lobar Degeneration: A Systematic Review and Meta-Analysis.

Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic study.

Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets.

'Under pressure': is there a link between orthostatic hypotension and cognitive impairment in α-synucleinopathies?

Characterizing familial corticobasal syndrome due to Alzheimer's disease pathology and PSEN1 mutations.

Lack of Frank Agrammatism in the Nonfluent Agrammatic Variant of Primary Progressive Aphasia.

The spatial coefficient of variation in arterial spin labeling cerebral blood flow images.

Small vessel disease is linked to disrupted structural network covariance in Alzheimer's disease.

Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers.

Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts.

Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson's disease.

The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward.

Development of cognitive screening test for the severely hearing impaired: Hearing-impaired MoCA.

Collagenosis of the Deep Medullary Veins: An Underrecognized Pathologic Correlate of White Matter Hyperintensities and Periventricular Infarction?

Comparison of arterial spin labeling registration strategies in the multi-center GENetic frontotemporal dementia initiative (GENFI).

White matter hyperintensities are seen only inmutation carriers in the GENFI cohort.

Heritability of hippocampal subfield volumes using a twin and non-twin siblings design.

Motor Phenotype in Neurodegenerative Disorders: Gait and Balance Platform Study Design Protocol for the Ontario Neurodegenerative Research Initiative (ONDRI).

Enhancement of automated blood flow estimates (ENABLE) from arterial spin-labeled MRI.

Peripheral lipid oxidative stress markers are related to vascular risk factors and subcortical small vessel disease.

Dopamine receptor D2 (DRD2), dopamine transporter solute carrier family C6, member 4 (SLC6A3), and catechol-O-methyltransferase (COMT) genes as moderators of the relation between maternal history of maltreatment and infant emotion regulation.

Maternal DRD2, SLC6A3, and OXTR genotypes as potential moderators of the relation between maternal history of care and maternal cortisol secretion in the context of mother-infant separation.

Deconstructing normal pressure hydrocephalus: Ventriculomegaly as early sign of neurodegeneration.

Sex differences in the prevalence of genetic mutations in FTD and ALS: A meta-analysis.

Unraveling PINK1 regulation: Ubiquitination of its mature form and insights for Parkinson's disease.

Disinhibition in Alzheimer's Disease is Associated with Reduced Right Frontal Pole Cortical Thickness.

Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study.

Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study.

The ONDRISeq panel: custom-designed next-generation sequencing of genes related to neurodegeneration.

Comment: Unraveling DNA sequence to identify cerebral indicators of dementia risk.

Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study.